Federated Hermes’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$195M Buy
1,813,505
+18,665
+1% +$2M 0.37% 65
2025
Q1
$181M Buy
1,794,840
+95,950
+6% +$9.68M 0.39% 56
2024
Q4
$152M Buy
1,698,890
+88,550
+5% +$7.91M 0.33% 71
2024
Q3
$135M Buy
1,610,340
+529,111
+49% +$44.3M 0.3% 75
2024
Q2
$83.3M Buy
1,081,229
+704,464
+187% +$54.3M 0.2% 124
2024
Q1
$25.8M Buy
376,765
+194,895
+107% +$13.3M 0.06% 361
2023
Q4
$10.5M Sell
181,870
-419
-0.2% -$24.2K 0.03% 549
2023
Q3
$9.62M Sell
182,289
-1,415
-0.8% -$74.7K 0.03% 536
2023
Q2
$9.94M Buy
183,704
+20,310
+12% +$1.1M 0.02% 540
2023
Q1
$8.17M Buy
163,394
+47,341
+41% +$2.37M 0.02% 593
2022
Q4
$5.37M Sell
116,053
-6,060
-5% -$280K 0.01% 671
2022
Q3
$4.73M Buy
122,113
+230
+0.2% +$8.91K 0.01% 685
2022
Q2
$4.54M Sell
121,883
-46,061
-27% -$1.72M 0.01% 710
2022
Q1
$7.44M Sell
167,944
-26,755
-14% -$1.18M 0.02% 683
2021
Q4
$8.27M Buy
194,699
+181,962
+1,429% +$7.73M 0.02% 701
2021
Q3
$553K Sell
12,737
-708
-5% -$30.7K ﹤0.01% 1482
2021
Q2
$575K Buy
13,445
+5,101
+61% +$218K ﹤0.01% 1476
2021
Q1
$322K Sell
8,344
-917,208
-99% -$35.4M ﹤0.01% 1631
2020
Q4
$33.3M Sell
925,552
-978,258
-51% -$35.2M 0.07% 334
2020
Q3
$72.7M Sell
1,903,810
-198,944
-9% -$7.6M 0.17% 142
2020
Q2
$73.8M Sell
2,102,754
-37,624
-2% -$1.32M 0.18% 129
2020
Q1
$69.8M Sell
2,140,378
-99,042
-4% -$3.23M 0.21% 109
2019
Q4
$101M Sell
2,239,420
-326
-0% -$14.7K 0.23% 96
2019
Q3
$91.1M Buy
2,239,746
+668
+0% +$27.2K 0.22% 100
2019
Q2
$96.2M Sell
2,239,078
-470,122
-17% -$20.2M 0.23% 96
2019
Q1
$104M Sell
2,709,200
-80,669
-3% -$3.1M 0.26% 79
2018
Q4
$98.6M Sell
2,789,869
-177,265
-6% -$6.26M 0.27% 78
2018
Q3
$114M Sell
2,967,134
-236,804
-7% -$9.12M 0.27% 78
2018
Q2
$105M Sell
3,203,938
-73,181
-2% -$2.39M 0.31% 73
2018
Q1
$89.5M Buy
3,277,119
+372,435
+13% +$10.2M 0.26% 80
2017
Q4
$72M Buy
2,904,684
+6,894
+0.2% +$171K 0.2% 99
2017
Q3
$84.5M Sell
2,897,790
-7,027
-0.2% -$205K 0.24% 82
2017
Q2
$80.5M Sell
2,904,817
-142,867
-5% -$3.96M 0.23% 83
2017
Q1
$75.8M Buy
3,047,684
+364,426
+14% +$9.06M 0.22% 86
2016
Q4
$58M Buy
2,683,258
+305,992
+13% +$6.62M 0.17% 114
2016
Q3
$56.6M Buy
2,377,266
+2,344,021
+7,051% +$55.8M 0.16% 113
2016
Q2
$777K Buy
33,245
+11,260
+51% +$263K ﹤0.01% 1163
2016
Q1
$414K Sell
21,985
-12,503
-36% -$235K ﹤0.01% 1325
2015
Q4
$636K Sell
34,488
-41,954
-55% -$774K ﹤0.01% 1220
2015
Q3
$1.26M Sell
76,442
-1,719
-2% -$28.2K ﹤0.01% 1027
2015
Q2
$1.38M Sell
78,161
-4,611
-6% -$81.6K ﹤0.01% 1047
2015
Q1
$1.47M Sell
82,772
-214,594
-72% -$3.81M ﹤0.01% 1054
2014
Q4
$3.94M Buy
297,366
+94,075
+46% +$1.25M 0.01% 702
2014
Q3
$2.4M Buy
203,291
+86,993
+75% +$1.03M 0.01% 895
2014
Q2
$1.49M Buy
116,298
+71,114
+157% +$908K ﹤0.01% 1054
2014
Q1
$611K Sell
45,184
-7,372
-14% -$99.7K ﹤0.01% 1290
2013
Q4
$631K Buy
52,556
+7,667
+17% +$92.1K ﹤0.01% 1270
2013
Q3
$527K Buy
44,889
+1,628
+4% +$19.1K ﹤0.01% 1288
2013
Q2
$401K Buy
+43,261
New +$401K ﹤0.01% 1339